Dexelance S.p.A. hereby announces that the Company's management will attend the following events dedicated to the financial community: on 8 April 2026, the “Equita Investor Access Conference 2026” – to be held in Paris at the congress center “Maison de la Chimie”; on 28 April 2026, the “Madrid MidCap Event” by Banca Akros – to be held in Madrid at the Wellington Hotel.

Dexelance S.p.A. hereby announces that today were filed: the Annual Financial Report as at 31 December 2025, drawn up in compliance with the requirements of the EU Directive 2022/2464; the Board of Statutory Auditors’ report; the Independent Auditors’ report; the report on corporate governance and ownership structure prepared pursuant to Article 123-bis of the Consolidated Financial Law; the report on remuneration policy and compensation paid prepared pursuant to Article 123-ter of the Consolidated Financial Law and Article 84-quater of the Issuers' Regulation.

Dexelance S.p.A. hereby announces that were filed today the notice of call for the ordinary shareholders' meeting convened on 27 April 2026, a single call, the proxy forms, the share capital information, as well as the explanatory reports relating to all items on the agenda.

Dexelance S.p.A. hereby announces that the following documents are available to the public: the Board of Directors’ guidelines on the optimal quantitative and qualitative composition of the Board, as approved at the meeting held on 16 March 2026; and the Board of Statutory Auditors’ guidelines regarding the composition of the Company’s new Board of Statutory Auditors.